<VariationArchive VariationID="2155" VariationName="NM_001127649.3(PEX26):c.[34dup;669_814+1del]" VariationType="Haplotype" Accession="VCV000002155" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2015-10-11" MostRecentSubmission="2023-04-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Haplotype VariationID="2155" NumberOfChromosomes="1">
      <SimpleAllele AlleleID="17193" VariationID="2154">
        <GeneList>
          <Gene Symbol="PEX26" FullName="peroxisomal biogenesis factor 26" GeneID="55670" HGNC_ID="HGNC:22965" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>22q11.21</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="18077990" stop="18105396" display_start="18077990" display_stop="18105396" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="18560685" stop="18573796" display_start="18560685" display_stop="18573796" Strand="+" />
            </Location>
            <OMIM>608666</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_001127649.3(PEX26):c.34dup (p.Leu12fs)</Name>
        <CanonicalSPDI>NC_000022.11:18078404:CCCCCC:CCCCCCC</CanonicalSPDI>
        <VariantType>Duplication</VariantType>
        <Location>
          <CytogeneticLocation>22q11.21</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="18078404" stop="18078405" display_start="18078404" display_stop="18078405" variantLength="1" positionVCF="18078404" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="18561170" stop="18561171" display_start="18561170" display_stop="18561171" variantLength="1" positionVCF="18561170" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        </Location>
        <ProteinChange>L12fs</ProteinChange>
        <HGVSlist>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_017929.5" sequenceAccession="NM_017929" sequenceVersion="5" change="c.34dupC">
              <Expression>NM_017929.5:c.34dupC</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_017929.5" sequenceAccession="NM_017929" sequenceVersion="5" change="c.29dupC">
              <Expression>NM_017929.5:c.29dupC</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.18561176dup" Assembly="GRCh37">
              <Expression>NC_000022.10:g.18561176dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.18078410dup" Assembly="GRCh38">
              <Expression>NC_000022.11:g.18078410dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_008339.1" sequenceAccession="NG_008339" sequenceVersion="1" change="g.5491dup">
              <Expression>NG_008339.1:g.5491dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_008339.2" sequenceAccession="NG_008339" sequenceVersion="2" change="g.5422dup">
              <Expression>NG_008339.2:g.5422dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_201355.1" sequenceAccession="NG_201355" sequenceVersion="1" change="g.157dup">
              <Expression>NG_201355.1:g.157dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001127649.3" sequenceAccession="NM_001127649" sequenceVersion="3" change="c.34dup" MANESelect="true">
              <Expression>NM_001127649.3:c.34dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001121121.1" sequenceAccession="NP_001121121" sequenceVersion="1" change="p.Leu12fs">
              <Expression>NP_001121121.1:p.Leu12fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001199319.2" sequenceAccession="NM_001199319" sequenceVersion="2" change="c.34dup">
              <Expression>NM_001199319.2:c.34dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001186248.1" sequenceAccession="NP_001186248" sequenceVersion="1" change="p.Leu12fs">
              <Expression>NP_001186248.1:p.Leu12fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_017929.6" sequenceAccession="NM_017929" sequenceVersion="6" change="c.34dup">
              <Expression>NM_017929.6:c.34dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_060399.1" sequenceAccession="NP_060399" sequenceVersion="1" change="p.Leu12fs">
              <Expression>NP_060399.1:p.Leu12fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2024-03-19" DateCreated="2011-01-25" MostRecentSubmission="2024-06-13" NumberOfSubmissions="11" NumberOfSubmitters="10">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">12851857</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">16257970</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">19877282</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">21031596</ID>
            </Citation>
            <Citation Type="general">
              <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PEX26</URL>
            </Citation>
            <ConditionList>
              <TraitSet ID="7944" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="5752" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Peroxisome biogenesis disorder</ElementValue>
                    <XRef ID="INHP_50" DB="Ege University Pediatric Genetics, Ege University" />
                    <XRef ID="MONDO:0019234" DB="MONDO" />
                    <XRef Type="Phenotypic series" ID="PS214100" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER (NALD/IRD)</ElementValue>
                    <XRef Type="MIM" ID="601539" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL</ElementValue>
                    <XRef Type="MIM" ID="601539" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER (NEONATAL ADRENOLEUKODYSTROPHY/INFANTILE REFSUM DISEASE)</ElementValue>
                    <XRef Type="MIM" ID="601539" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">INFANTILE PHYTANIC ACID STORAGE DISEASE</ElementValue>
                    <XRef Type="MIM" ID="601539" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Peroxisome biogenesis disorders, Zellweger syndrome spectrum</ElementValue>
                    <XRef ID="Peroxisome+biogenesis+disorders/5684" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">ALD: Adrenoleukodystrophy, X-Linked</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">PBDS</ElementValue>
                    <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Preferred">PBD, ZSS</ElementValue>
                    <XRef ID="NBK1448" DB="GeneReviews" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="11890" />
                    <XRef ID="11890" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                    <XRef ID="GTR000028503" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501632" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000525961" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501473" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501644" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000520399" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501628" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501626" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000318883" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501635" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000318975" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000028499" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501634" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501631" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501629" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000318886" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501633" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000593050" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501474" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000070509" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000004880" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000070507" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501472" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501630" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501647" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501625" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000501466" DB="Genetic Testing Registry (GTR)" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                    <XRef ID="NBK1448" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301621</ID>
                    <ID Source="BookShelf">NBK1448</ID>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                    <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                    <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                    <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
                  </Citation>
                  <XRef ID="79189" DB="Orphanet" />
                  <XRef ID="C1832200" DB="MedGen" />
                  <XRef ID="MONDO:0019234" DB="MONDO" />
                  <XRef Type="Phenotypic series" ID="PS214100" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="10245" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17437" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Peroxisome biogenesis disorder 7B</ElementValue>
                    <XRef ID="MONDO:0013939" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">PBD7B</ElementValue>
                    <XRef Type="MIM" ID="614873" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="15867" />
                    <XRef ID="15867" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum (ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment. Children with the NALD presentation may reach their teens, and those with the IRD presentation may reach adulthood (summary by Waterham and Ebberink, 2012).
For a complete phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD), see 601539.
Individuals with mutations in the PEX26 gene have cells of complementation group 8 (CG8, equivalent to CGA). For information on the history of PBD complementation groups, see 214100.</Attribute>
                    <XRef Type="MIM" ID="614873" DB="OMIM" />
                  </AttributeSet>
                  <XRef ID="44" DB="Orphanet" />
                  <XRef ID="C3553951" DB="MedGen" />
                  <XRef ID="MONDO:0013939" DB="MONDO" />
                  <XRef Type="MIM" ID="614873" DB="OMIM" />
                </Trait>
                <Trait ID="17436" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Peroxisome biogenesis disorder 7A (Zellweger)</ElementValue>
                    <XRef ID="MONDO:0013938" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Peroxisome biogenesis disorder 7A</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">PBD7A</ElementValue>
                    <XRef ID="GTR000522755" DB="Genetic Testing Registry (GTR)" />
                    <XRef Type="MIM" ID="614872" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="15866" />
                    <XRef ID="15866" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 8 (CG8, equivalent to CGA) have mutations in the PEX26 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                    <XRef Type="MIM" ID="614872" DB="OMIM" />
                  </AttributeSet>
                  <XRef ID="912" DB="Orphanet" />
                  <XRef ID="C3888385" DB="MedGen" />
                  <XRef ID="MONDO:0013938" DB="MONDO" />
                  <XRef Type="MIM" ID="614872" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="8956" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17436" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Peroxisome biogenesis disorder 7A (Zellweger)</ElementValue>
                    <XRef ID="MONDO:0013938" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Peroxisome biogenesis disorder 7A</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">PBD7A</ElementValue>
                    <XRef ID="GTR000522755" DB="Genetic Testing Registry (GTR)" />
                    <XRef Type="MIM" ID="614872" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="15866" />
                    <XRef ID="15866" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 8 (CG8, equivalent to CGA) have mutations in the PEX26 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                    <XRef Type="MIM" ID="614872" DB="OMIM" />
                  </AttributeSet>
                  <XRef ID="912" DB="Orphanet" />
                  <XRef ID="C3888385" DB="MedGen" />
                  <XRef ID="MONDO:0013938" DB="MONDO" />
                  <XRef Type="MIM" ID="614872" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="8957" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17437" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Peroxisome biogenesis disorder 7B</ElementValue>
                    <XRef ID="MONDO:0013939" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">PBD7B</ElementValue>
                    <XRef Type="MIM" ID="614873" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="15867" />
                    <XRef ID="15867" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum (ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment. Children with the NALD presentation may reach their teens, and those with the IRD presentation may reach adulthood (summary by Waterham and Ebberink, 2012).
For a complete phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD), see 601539.
Individuals with mutations in the PEX26 gene have cells of complementation group 8 (CG8, equivalent to CGA). For information on the history of PBD complementation groups, see 214100.</Attribute>
                    <XRef Type="MIM" ID="614873" DB="OMIM" />
                  </AttributeSet>
                  <XRef ID="44" DB="Orphanet" />
                  <XRef ID="C3553951" DB="MedGen" />
                  <XRef ID="MONDO:0013939" DB="MONDO" />
                  <XRef Type="MIM" ID="614873" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="2155" DB="ClinVar" />
          <XRef ID="CA115371" DB="ClinGen" />
          <XRef Type="Allelic variant" ID="608666.0003" DB="OMIM" />
          <XRef Type="Allelic variant" ID="608666.0004" DB="OMIM" />
          <XRef Type="rs" ID="61752129" DB="dbSNP" />
        </XRefList>
      </SimpleAllele>
      <SimpleAllele AlleleID="17194" VariationID="2627654">
        <GeneList>
          <Gene Symbol="PEX26" FullName="peroxisomal biogenesis factor 26" GeneID="55670" HGNC_ID="HGNC:22965" Source="submitted" RelationshipType="asserted, but not computed">
            <Location>
              <CytogeneticLocation>22q11.21</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="18077990" stop="18105396" display_start="18077990" display_stop="18105396" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="18560685" stop="18573796" display_start="18560685" display_stop="18573796" Strand="+" />
            </Location>
            <OMIM>608666</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_001127649.3(PEX26):c.669_814+1del</Name>
        <VariantType>Deletion</VariantType>
        <Location>
          <CytogeneticLocation>22q11.21</CytogeneticLocation>
        </Location>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.18567879_18568025del" Assembly="GRCh37">
              <Expression>NC_000022.10:g.18567879_18568025del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.18085113_18085259del" Assembly="GRCh38">
              <Expression>NC_000022.11:g.18085113_18085259del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_008339.1" sequenceAccession="NG_008339" sequenceVersion="1" change="g.12194_12340del">
              <Expression>NG_008339.1:g.12194_12340del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_008339.2" sequenceAccession="NG_008339" sequenceVersion="2" change="g.12125_12271del">
              <Expression>NG_008339.2:g.12125_12271del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001127649.3" sequenceAccession="NM_001127649" sequenceVersion="3" change="c.669_814+1del" MANESelect="true">
              <Expression>NM_001127649.3:c.669_814+1del</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_017929.6" sequenceAccession="NM_017929" sequenceVersion="6" change="c.669_814+1del">
              <Expression>NM_017929.6:c.669_814+1del</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001199319.2" sequenceAccession="NM_001199319" sequenceVersion="2" change="c.667+1381_667+1527del">
              <Expression>NM_001199319.2:c.667+1381_667+1527del</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </GermlineClassification>
          <SomaticClinicalImpact NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </SomaticClinicalImpact>
          <OncogenicityClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </OncogenicityClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Allelic variant" ID="608666.0004" DB="OMIM" />
          <XRef Type="rs" ID="2123657325" DB="dbSNP" />
          <XRef Type="Interpreted" ID="2155" DB="ClinVar" />
        </XRefList>
        <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">This deletion was characterized by RT-PCR, and appears to represent skipping of an exon. The genomic basis of this observation was not reported in the paper by Matsumoto et al., 2003 (PubMed 12717447).</Comment>
      </SimpleAllele>
      <Name>NM_001127649.3(PEX26):c.[34dup;669_814+1del]</Name>
      <VariationType>Haplotype</VariationType>
      <OtherNameList>
        <Name>PEX26, 1-BP INS, 35C AND 147-BP DEL, NT668</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression MANESelect="true">
            <Expression>NM_001127649.3:c.[34dup;669_814+1del]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA210677" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="608666.0004" DB="OMIM" />
      </XRefList>
    </Haplotype>
    <RCVList>
      <RCVAccession Title="NM_001127649.3(PEX26):c.[34dup;669_814+1del] AND Peroxisome biogenesis disorder 7A (Zellweger)" Accession="RCV000002238" Version="12">
        <ClassifiedConditionList TraitSetID="8956">
          <ClassifiedCondition DB="MedGen" ID="C3888385">Peroxisome biogenesis disorder 7A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2003-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-10-11" MostRecentSubmission="2023-04-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12851857</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8956" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17436" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 7A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013938" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 7A</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD7A</ElementValue>
                <XRef ID="GTR000522755" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614872" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 8 (CG8, equivalent to CGA) have mutations in the PEX26 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614872" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15866" />
                <XRef ID="15866" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3888385" DB="MedGen" />
              <XRef ID="MONDO:0013938" DB="MONDO" />
              <XRef Type="MIM" ID="614872" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="22396" SubmissionDate="2017-02-06" DateLastUpdated="2023-04-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608666.0004_PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)" title="PEX26, 1-BP INS, 35C AND 147-BP DEL, NT668_PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)" />
        <ClinVarAccession Accession="SCV000022396" DateUpdated="2023-04-23" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of an allele containing a 1-bp insertion in the PEX26 gene (T35insC) in cis with a 147-bp deletion in the PEX26 gene that was found in compound heterozygous state in a patient (cell line GM07371) with Zellweger syndrome (PBD7A; 614872) by Matsumoto et al. (2003), see 608666.0003.</Attribute>
              <Citation>
                <ID Source="PubMed">12851857</ID>
              </Citation>
              <XRef DB="OMIM" ID="614872" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX26" />
          </GeneList>
          <Name>PEX26, 1-BP INS, 35C AND 147-BP DEL, NT668</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 35C AND 147-BP DEL, NT668</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608666.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="22396" TraitType="Disease" MappingType="Name" MappingValue="PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)" MappingRef="Preferred">
        <MedGen CUI="C3888385" Name="Peroxisome biogenesis disorder 7A (Zellweger)" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>